Title of Collaborative Activity: |
Memorandum of Understanding (MOU) between the FDA/Center for Biologics Evaluation and Research (FDA/CBER) and NIH/NINDS |
Description of Collaborative Activity: |
This MOU provides a mechanism for addressing cross-cutting issues related to therapy development for neurological disorders, from bench science to clinical trials and FDA approval and licensure. |
Type of Collaborative Activity: |
Select Type of Collaborative Activity
|
Year the Collaborative Activity Originated: |
2002 |
NIH Participating Institutes/Centers/Office of the Director: |
NINDS |
HHS Agency Collaborators on this Activity: |
FDA |
